Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Lake Elsinore, CA, June 29, 2022 (GLOBE NEWSWIRE) -- IGEN Networks Corporation (OTC: IGEN) (CSE: IGN), a leading innovator of Internet of Things (IoT) solutions for the consumer automotive and...
-
TERRITORIES OF MUSQUEAM, SQUAMISH AND TSLEIL-WAUTUTH NATIONS and VANCOUVER, British Columbia, June 29, 2022 (GLOBE NEWSWIRE) -- Vancity today took an important next step on its commitment to...
-
SHENZHEN, China, June 29, 2022 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in...
-
ICG Enterprise Trust Plc: Portfolio Update - ICG Enterprise Trust makes three new direct investments
ICG Enterprise Trust plc Portfolio Update 29 June 2022 ICG Enterprise Trust makes three new direct investments ICG Enterprise Trust plc (ICGT) is pleased to announce that it has recently...
-
New York, June 29, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Mini Excavators Market Size, Share & Industry Trends Analysis Report By Type, By...
-
Pune, India, June 29, 2022 (GLOBE NEWSWIRE) -- The global neurodegenerative diseases drugs market is likely to gain traction from the rising incidence of neurodegenerative diseases worldwide. Such...
-
Pune, June 29, 2022 (GLOBE NEWSWIRE) -- The global bitumen emulsifier market size is projected to hit $72.54 million by 2028 and exhibit a CAGR of 5.6% during the 2021-2028 period. The expanding...
-
On 3 March 2022, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the...
-
Oslo, 29 June 2022 - Please see below information about transactions made under the buy-back programme for Adevinta ASA. Following the announced duration of the buy-back programme, the second tranche...
-
SAN FRANCISCO, June 29, 2022 (GLOBE NEWSWIRE) -- 89bio, Inc. (“89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative...